Antibiotics | Recruiting Section Editor-in-Chief for Section “Fungi and Their Metabolites”

To develop different research areas and continue to attract high-quality papers, Antibiotics (ISSN: 2079-6382) is recruiting a Section Editor-in-Chief for the Section “Fungi and Their Metabolites”.

The main responsibilities of the Section Editors-in-Chief are as follows:

• Supervising the quality of the papers in their Section (when we have new submissions to the Section);
• Acting as or recommending a Guest Editor for a Special Issue on a topic related to your research interests;
• Providing conference/society cooperation recommendations.

This position is open to experts on related aspects of antibiotics. To apply for this position, recommend potential candidates, or request further information, please contact the Antibiotics Editorial Office (antibiotics@mdpi.com) or the Managing Editor, Ms. Jocelyn Yang (jocelyn.yang@mdpi.com).

Antibiotics is an international, peer-reviewed, open access journal published online by MDPI, Basel, Switzerland. The scope of Antibiotics includes, but is not limited to, the following: pharmacodynamics, uses of antibiotics, antimicrobial stewardship, antibiotic resistance, and novel antimicrobial agents. We encourage scientists to publish their experimental and theoretical results in as much detail as possible. The journal has been indexed by the Science Citation Index Expanded (SCIE: Web of Science), Scopus, and other databases. Citations are available on PubMed; full texts are archived in PubMed Central. The Impact Factor for Antibiotics (2022) is 4.8, ranking Q1 in the “Pharmacology & Pharmacy” category and Q2 in the “Infectious Diseases” category.